CommentBulevirtide and tenofovir combination therapy for hepatitis D virus infection: longer treatment and more diverse trial populations are needed
References (10)
- et al.
The global prevalence of hepatitis D virus infection: systematic review and meta-analysis
J Hepatol
(2020) - et al.
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies
J Hepatol
(2020) - et al.
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
JHEP Rep
(2019) - et al.
Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options
Nat Rev Gastroenterol Hepatol
(2016) - et al.
Hepatitis D: not a rare disease anymore: global update for 2017-2018
Gut
(2020)
There are more references available in the full text version of this article.
Cited by (0)
© 2022 Elsevier Ltd. All rights reserved.